COVID-19

News

GSK gets £1.4bn sales lift from COVID-19 products in 2021

GlaxoSmithKline's COVID-19 products – antibody drug Xevudy and a vaccine adjuvant – helped drive a 5% increase in 2021 revenues to £34 billion ($46 billion), ahead of what chief executive E

News

Data hackathon analyses truth behind ‘game-changer’ COVID vaccine

Novavax COVID jab 'could save UK money on boosters'

The approval of Novavax' COVID-19 vaccine in Great Britain could help the country save a "considerable amount of money" if it is used in future booster campaigns, according to the former ch

News

COVID kits boosted Roche last year, but 2022 will be tougher

Roche has warned that revenue growth will come under pressure in the coming year as sales of its COVID-19 testing kits start to slow, exposing the impact of biosimilar competition to some o

R&D

How NINR project is solidifying UK’s remote trial know how

Assumptions to evidence: How NIHR project is solidifying UK’...

Remote, virtual, or decentralised clinical trials are nothing new, but COVID-19 catapulted the model into the mainstream.

Digital

Addressing the UK digital skills gap

Over the past two years, life sciences media has been flooded with headlines about the rise of digital health systems.

Digital

Optimised clinical research through decentralised trials

Not only did the COVID-19 pandemic bring lockdown rules and increased safety protocols, it also led to delays, reconfigurations, limited patient access, and other restrictions for life scie

GSK gets £1.4bn sales lift from COVID-19 products in 2021

Novavax COVID jab 'could save UK money on boosters'

COVID kits boosted Roche last year, but 2022 will be tougher

Assumptions to evidence: How NIHR project is solidifying UK’...

Addressing the UK digital skills gap

Optimised clinical research through decentralised trials

Wave's stock wavers on obesity drug data

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks